Read current information and the list of products at:
About pholcodine cough medicines cancelled by the TGA
After a TGA safety investigation 55 products containing pholcodine are being cancelled from the Australian Register of Therapeutic Goods. The 44 products on pharmacy shelves are now part of a recall.
There is a link between these medicines and an increased risk of serious allergic reaction to some medicines used for general anaesthetic.
Pholcodine was used in a wide range of over the counter pharmacy medicines like syrups and lozenges, to treat a dry cough. It was also combined with other medicines in products to treat the symptoms of cold and flu. All products containing pholcodine are part of this recall.
3 result(s) found, displaying 1 to 3
- Safety updatesCheck for pholcodine use before general anaesthesiaHealth professionals should check if patients undergoing general anaesthesia have used products containing pholcodine in the previous 12 months.
- Safety alertsPholcodineThe TGA has decided to cancel the registration of pholcodine-containing medicines and is recalling them from pharmacies.
- Media releasesPholcodine cough medicines cancelled by the TGA and recalled from pharmacies for safety reasonsFollowing a safety investigation into pholcodine the TGA are cancelling 55 products (from the ARTG) and recalling them from pharmacy shelves due to an increased risk of anaphylactic reactions.